Park Place Capital Corp reduced its holdings in Danaher Co. (NYSE:DHR – Free Report) by 4.7% in the 4th quarter, Holdings Channel reports. The fund owned 1,046 shares of the conglomerate’s stock after selling 52 shares during the quarter. Park Place Capital Corp’s holdings in Danaher were worth $240,000 at the end of the most recent quarter.
Several other institutional investors have also modified their holdings of the business. Daymark Wealth Partners LLC lifted its holdings in shares of Danaher by 0.9% in the fourth quarter. Daymark Wealth Partners LLC now owns 17,521 shares of the conglomerate’s stock valued at $4,022,000 after purchasing an additional 155 shares in the last quarter. Albion Financial Group UT raised its position in Danaher by 360.7% in the 4th quarter. Albion Financial Group UT now owns 1,290 shares of the conglomerate’s stock valued at $296,000 after buying an additional 1,010 shares during the last quarter. Beaumont Financial Advisors LLC lifted its stake in Danaher by 59.4% in the 4th quarter. Beaumont Financial Advisors LLC now owns 2,958 shares of the conglomerate’s stock valued at $679,000 after acquiring an additional 1,102 shares in the last quarter. Bourgeon Capital Management LLC boosted its position in Danaher by 7.4% during the 4th quarter. Bourgeon Capital Management LLC now owns 60,178 shares of the conglomerate’s stock worth $13,814,000 after acquiring an additional 4,150 shares during the last quarter. Finally, Roberts Wealth Advisors LLC grew its stake in shares of Danaher by 18.8% during the 4th quarter. Roberts Wealth Advisors LLC now owns 950 shares of the conglomerate’s stock worth $226,000 after acquiring an additional 150 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.
Analyst Ratings Changes
Several brokerages recently commented on DHR. UBS Group reduced their target price on shares of Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. Robert W. Baird reduced their price objective on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Wolfe Research raised Danaher from a “peer perform” rating to an “outperform” rating and set a $285.00 target price on the stock in a research report on Thursday, October 31st. TD Cowen increased their price target on Danaher from $310.00 to $315.00 and gave the company a “buy” rating in a research report on Wednesday, October 23rd. Finally, Raymond James lowered their price target on Danaher from $300.00 to $275.00 and set an “outperform” rating on the stock in a research report on Tuesday. Six investment analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and an average price target of $285.55.
Danaher Stock Up 0.0 %
Danaher stock opened at $244.19 on Thursday. The company’s 50-day moving average price is $234.84 and its two-hundred day moving average price is $253.53. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The stock has a market cap of $176.38 billion, a P/E ratio of 46.60, a P/E/G ratio of 4.30 and a beta of 0.83. Danaher Co. has a twelve month low of $225.42 and a twelve month high of $281.70.
Danaher (NYSE:DHR – Get Free Report) last announced its earnings results on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. The company had revenue of $5.80 billion for the quarter, compared to analyst estimates of $5.59 billion. Danaher had a return on equity of 10.62% and a net margin of 16.39%. The firm’s quarterly revenue was up 3.1% compared to the same quarter last year. During the same quarter last year, the company earned $2.02 earnings per share. As a group, analysts expect that Danaher Co. will post 7.49 EPS for the current year.
Danaher Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be given a dividend of $0.27 per share. This represents a $1.08 annualized dividend and a yield of 0.44%. The ex-dividend date of this dividend is Friday, December 27th. Danaher’s payout ratio is 20.61%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Further Reading
- Five stocks we like better than Danaher
- Most Volatile Stocks, What Investors Need to Know
- Oracle Announces Game-Changing News for the AI Industry
- Investing In Preferred Stock vs. Common Stock
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- There Are Different Types of Stock To Invest In
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.